Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2016 | 2 |
2017 | 1 |
2020 | 1 |
2021 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
5 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Therapeutic Targeting of LIF Overcomes Macrophage-mediated Immunosuppression of the Local Tumor Microenvironment.
Clin Cancer Res. 2023 Feb 16;29(4):791-804. doi: 10.1158/1078-0432.CCR-21-1888.
Clin Cancer Res. 2023.
PMID: 36441800
Enhanced immunotherapeutic profile of oncolytic virus-based cancer vaccination using cyclophosphamide preconditioning.
Pol JG, Atherton MJ, Stephenson KB, Bridle BW, Workenhe ST, Kazdhan N, McGray AR, Wan Y, Kroemer G, Lichty BD.
Pol JG, et al. Among authors: mcgray ar.
J Immunother Cancer. 2020 Aug;8(2):e000981. doi: 10.1136/jitc-2020-000981.
J Immunother Cancer. 2020.
PMID: 32792361
Free PMC article.
Item in Clipboard
CXCR6 by increasing retention of memory CD8+ T cells in the ovarian tumor microenvironment promotes immunosurveillance and control of ovarian cancer.
Muthuswamy R, McGray AR, Battaglia S, He W, Miliotto A, Eppolito C, Matsuzaki J, Takemasa T, Koya R, Chodon T, Lichty BD, Shrikant P, Odunsi K.
Muthuswamy R, et al. Among authors: mcgray ar.
J Immunother Cancer. 2021 Oct;9(10):e003329. doi: 10.1136/jitc-2021-003329.
J Immunother Cancer. 2021.
PMID: 34607898
Free PMC article.
Item in Clipboard
Reprogramming antitumor immunity against chemoresistant ovarian cancer by a CXCR4 antagonist-armed viral oncotherapy.
Komorowski MP, McGray AR, Kolakowska A, Eng K, Gil M, Opyrchal M, Litwinska B, Nemeth MJ, Odunsi KO, Kozbor D.
Komorowski MP, et al. Among authors: mcgray ar.
Mol Ther Oncolytics. 2016 Dec 14;3:16034. doi: 10.1038/mto.2016.34. eCollection 2016.
Mol Ther Oncolytics. 2016.
PMID: 28035333
Free PMC article.
Item in Clipboard
Compensatory upregulation of PD-1, LAG-3, and CTLA-4 limits the efficacy of single-agent checkpoint blockade in metastatic ovarian cancer.
Huang RY, Francois A, McGray AR, Miliotto A, Odunsi K.
Huang RY, et al. Among authors: mcgray ar.
Oncoimmunology. 2016 Oct 28;6(1):e1249561. doi: 10.1080/2162402X.2016.1249561. eCollection 2017.
Oncoimmunology. 2016.
PMID: 28197366
Free PMC article.
Item in Clipboard
Cite
Cite